C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies

Ellen Toyonaga, Wataru Nishie, Kentaro Izumi, Ken Natsuga, Hideyuki Ujiie, Hiroaki Iwata, Jun Yamagami, Yoshiaki Hirako, Daisuke Sawamura, Wataru Fujimoto, Hiroshi Shimizu

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Transmembrane collagen XVII (COL17) is a hemidesmosomal component of basal keratinocytes that can be targeted by autoantibodies in autoimmune blistering disorders, including linear IgA dermatosis (LAD). COL17 can be physiologically cleaved within the juxtamembranous extracellular NC16A domain, and LAD autoantibodies preferentially react with the processed ectodomains, indicating that the processing induces neoepitopes. However, the details of how neoepitopes develop have not been elucidated. In this study, we show that C-terminal processing of COL17 also plays a role in inducing neoepitopes for LAD autoantibodies. First, the mAb hC17-ect15 targeting the 15th collagenous domain of COL17 was produced, which showed characteristics similar to LAD autoantibodies. The mAbs preferentially reacted with C-terminally deleted (up to 682 amino acids) recombinant COL17, suggesting that C-terminal processing shows neoepitopes on the 15th collagenous domain. The LAD autoantibodies also react with C-terminal deleted COL17. Therefore, neoepitopes for LAD autoantibodies also develop after C-terminal processing. Finally, the passive transfer of the mAb hC17-ect15 into human COL17-expressing transgenic mice failed to induce blistering disease, suggesting that neoepitope-targeting antibodies are not always pathogenic. In summary, this study shows that C-terminal processing induces dynamic structural changes and neoepitopes for LAD autoantibodies on COL17.

Original languageEnglish
Pages (from-to)2552-2559
Number of pages8
JournalJournal of Investigative Dermatology
Volume137
Issue number12
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Linear IgA Bullous Dermatosis
Autoantibodies
Immunoglobulin A
Processing
Structural dynamics
collagen type XVII
Keratinocytes
Transgenic Mice
Amino Acids
Antibodies

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Toyonaga, E., Nishie, W., Izumi, K., Natsuga, K., Ujiie, H., Iwata, H., ... Shimizu, H. (2017). C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies. Journal of Investigative Dermatology, 137(12), 2552-2559. https://doi.org/10.1016/j.jid.2017.07.831

C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies. / Toyonaga, Ellen; Nishie, Wataru; Izumi, Kentaro; Natsuga, Ken; Ujiie, Hideyuki; Iwata, Hiroaki; Yamagami, Jun; Hirako, Yoshiaki; Sawamura, Daisuke; Fujimoto, Wataru; Shimizu, Hiroshi.

In: Journal of Investigative Dermatology, Vol. 137, No. 12, 01.12.2017, p. 2552-2559.

Research output: Contribution to journalArticle

Toyonaga, E, Nishie, W, Izumi, K, Natsuga, K, Ujiie, H, Iwata, H, Yamagami, J, Hirako, Y, Sawamura, D, Fujimoto, W & Shimizu, H 2017, 'C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies', Journal of Investigative Dermatology, vol. 137, no. 12, pp. 2552-2559. https://doi.org/10.1016/j.jid.2017.07.831
Toyonaga, Ellen ; Nishie, Wataru ; Izumi, Kentaro ; Natsuga, Ken ; Ujiie, Hideyuki ; Iwata, Hiroaki ; Yamagami, Jun ; Hirako, Yoshiaki ; Sawamura, Daisuke ; Fujimoto, Wataru ; Shimizu, Hiroshi. / C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies. In: Journal of Investigative Dermatology. 2017 ; Vol. 137, No. 12. pp. 2552-2559.
@article{af902d15da8a4c029e13b22a8017d469,
title = "C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies",
abstract = "Transmembrane collagen XVII (COL17) is a hemidesmosomal component of basal keratinocytes that can be targeted by autoantibodies in autoimmune blistering disorders, including linear IgA dermatosis (LAD). COL17 can be physiologically cleaved within the juxtamembranous extracellular NC16A domain, and LAD autoantibodies preferentially react with the processed ectodomains, indicating that the processing induces neoepitopes. However, the details of how neoepitopes develop have not been elucidated. In this study, we show that C-terminal processing of COL17 also plays a role in inducing neoepitopes for LAD autoantibodies. First, the mAb hC17-ect15 targeting the 15th collagenous domain of COL17 was produced, which showed characteristics similar to LAD autoantibodies. The mAbs preferentially reacted with C-terminally deleted (up to 682 amino acids) recombinant COL17, suggesting that C-terminal processing shows neoepitopes on the 15th collagenous domain. The LAD autoantibodies also react with C-terminal deleted COL17. Therefore, neoepitopes for LAD autoantibodies also develop after C-terminal processing. Finally, the passive transfer of the mAb hC17-ect15 into human COL17-expressing transgenic mice failed to induce blistering disease, suggesting that neoepitope-targeting antibodies are not always pathogenic. In summary, this study shows that C-terminal processing induces dynamic structural changes and neoepitopes for LAD autoantibodies on COL17.",
author = "Ellen Toyonaga and Wataru Nishie and Kentaro Izumi and Ken Natsuga and Hideyuki Ujiie and Hiroaki Iwata and Jun Yamagami and Yoshiaki Hirako and Daisuke Sawamura and Wataru Fujimoto and Hiroshi Shimizu",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.jid.2017.07.831",
language = "English",
volume = "137",
pages = "2552--2559",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies

AU - Toyonaga, Ellen

AU - Nishie, Wataru

AU - Izumi, Kentaro

AU - Natsuga, Ken

AU - Ujiie, Hideyuki

AU - Iwata, Hiroaki

AU - Yamagami, Jun

AU - Hirako, Yoshiaki

AU - Sawamura, Daisuke

AU - Fujimoto, Wataru

AU - Shimizu, Hiroshi

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Transmembrane collagen XVII (COL17) is a hemidesmosomal component of basal keratinocytes that can be targeted by autoantibodies in autoimmune blistering disorders, including linear IgA dermatosis (LAD). COL17 can be physiologically cleaved within the juxtamembranous extracellular NC16A domain, and LAD autoantibodies preferentially react with the processed ectodomains, indicating that the processing induces neoepitopes. However, the details of how neoepitopes develop have not been elucidated. In this study, we show that C-terminal processing of COL17 also plays a role in inducing neoepitopes for LAD autoantibodies. First, the mAb hC17-ect15 targeting the 15th collagenous domain of COL17 was produced, which showed characteristics similar to LAD autoantibodies. The mAbs preferentially reacted with C-terminally deleted (up to 682 amino acids) recombinant COL17, suggesting that C-terminal processing shows neoepitopes on the 15th collagenous domain. The LAD autoantibodies also react with C-terminal deleted COL17. Therefore, neoepitopes for LAD autoantibodies also develop after C-terminal processing. Finally, the passive transfer of the mAb hC17-ect15 into human COL17-expressing transgenic mice failed to induce blistering disease, suggesting that neoepitope-targeting antibodies are not always pathogenic. In summary, this study shows that C-terminal processing induces dynamic structural changes and neoepitopes for LAD autoantibodies on COL17.

AB - Transmembrane collagen XVII (COL17) is a hemidesmosomal component of basal keratinocytes that can be targeted by autoantibodies in autoimmune blistering disorders, including linear IgA dermatosis (LAD). COL17 can be physiologically cleaved within the juxtamembranous extracellular NC16A domain, and LAD autoantibodies preferentially react with the processed ectodomains, indicating that the processing induces neoepitopes. However, the details of how neoepitopes develop have not been elucidated. In this study, we show that C-terminal processing of COL17 also plays a role in inducing neoepitopes for LAD autoantibodies. First, the mAb hC17-ect15 targeting the 15th collagenous domain of COL17 was produced, which showed characteristics similar to LAD autoantibodies. The mAbs preferentially reacted with C-terminally deleted (up to 682 amino acids) recombinant COL17, suggesting that C-terminal processing shows neoepitopes on the 15th collagenous domain. The LAD autoantibodies also react with C-terminal deleted COL17. Therefore, neoepitopes for LAD autoantibodies also develop after C-terminal processing. Finally, the passive transfer of the mAb hC17-ect15 into human COL17-expressing transgenic mice failed to induce blistering disease, suggesting that neoepitope-targeting antibodies are not always pathogenic. In summary, this study shows that C-terminal processing induces dynamic structural changes and neoepitopes for LAD autoantibodies on COL17.

UR - http://www.scopus.com/inward/record.url?scp=85034986319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034986319&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2017.07.831

DO - 10.1016/j.jid.2017.07.831

M3 - Article

C2 - 28842325

AN - SCOPUS:85034986319

VL - 137

SP - 2552

EP - 2559

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 12

ER -